Trials / Conditions / Group B Streptococcal Infections
Group B Streptococcal Infections
5 registered clinical trials studyying Group B Streptococcal Infections.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, A NCT06611371 | Inventprise Inc. | Phase 1 / Phase 2 |
| Completed | Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Partici NCT05782179 | Minervax ApS | Phase 1 |
| Completed | A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS NCT04258995 | Pfizer | Phase 2 |
| Unknown | Invasive Group B Streptococcus Disease Burden and Its Antimicrobial Resistance in Malaysia Among Non-pregnant NCT05726006 | Universiti Putra Malaysia | — |
| Completed | A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And NCT03170609 | Pfizer | Phase 2 |